Emerging Infectious Diseases (Oct 2010)

Epidemiology of Human Parvovirus 4 Infection in Sub-Saharan Africa

  • Colin P. Sharp,
  • Marion Vermeulen,
  • Yacouba K. Nébié,
  • Cyrille F. Djoko,
  • Matthew LeBreton,
  • Ubald Tamoufe,
  • Anne W. Rimoin,
  • Patrick K. Kayembe,
  • Jean K. Carr,
  • Annabelle Servant-Delmas,
  • Syria Laperche,
  • G.L. Abby Harrison,
  • Oliver G. Pybus,
  • Eric Delwart,
  • Nathan D. Wolfe,
  • Andrew Saville,
  • Jean-Jacques Lefrère,
  • Peter Simmonds

DOI
https://doi.org/10.3201/eid1610.101001
Journal volume & issue
Vol. 16, no. 10
pp. 1605 – 1607

Abstract

Read online

Human parvovirus 4 infections are primarily associated with parenteral exposure in western countries. By ELISA, we demonstrate frequent seropositivity for antibody to parvovirus 4 viral protein 2 among adult populations throughout sub-Saharan Africa (Burkina Faso, 37%; Cameroon, 25%; Democratic Republic of the Congo, 35%; South Africa, 20%), which implies existence of alternative transmission routes.

Keywords